Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: A novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 4, 2007, Pages 337-340

  Lee, Paul ^a   Jones, Graham ^b   Seibel, Markus J ^a  

^a ANZAC Research Institute   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Gilbert's syndrome; Hyperserotoninaemia; Polymorphism; Serotonin; Uridine diphosphate glucuronosyltransferases

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CARCINOID SYNDROME; CASE REPORT; DIARRHEA; DISEASE ASSOCIATION; FEMALE; FLUSHING; GENETIC POLYMORPHISM; GILBERT DISEASE; HUMAN; HYPERSEROTONINEMIA; METABOLIC DISORDER; NIGHT SWEAT; PRIORITY JOURNAL;

ADULT; CARCINOID TUMOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; GILBERT DISEASE; GLUCURONOSYLTRANSFERASE; HUMANS; POLYMORPHISM, GENETIC; SEROTONIN;

EID: 33947112435     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328012b431     Document Type: Article

References (23)

1. Giannini AJ, Malone DA, Piotrowski TA. The serotonin irritation syndrome: a new clinical entity? J Clin Psychiatry 1986; 47:22-25.
2. Warner RR. Hyperserotoninemia in functional gastrointestinal disease. Ann Intern Med 1963; 59:464-470.
3. Warner RR. Monoamine oxidase deficiency: a cause of symptomatic hyperserotoninemia in the absence of carcinoid. Arch Intern Med 2002; 162:1647-1648.
4. Warner RR. Serotonin irritation syndrome. J Clin Psychiatry 1987; 48:217.
5. Cheung NW, Earl J. Monoamine oxidase deficiency: a cause of flushing and attention-deficit/hyperactivity disorder? Arch Intern Med 2001; 161:2503-2504.
6. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995; 333:1171-1175.
7. Gitlin N. The clinical presentation of Gilbert's disease in 26 patients. S Afr Med J 1977; 52:19-20.
8. Powell LW, Hemingway E, Billing BH, Sherlock S. Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): a study of 42 families. N Engl J Med 1967; 277:1108.
9. Gilbertssyndrome.org.uk [homepage on the internet]. Actions on Gilbert Syndrome [cited 7 June 2006]. Available from www.gilbertssyndrome. org.uk
10. Bock KW, Kohle C. UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Methods Enzymol 2005; 400:57-75.
11. Bloom FE. Serotonin neurons: localization and possible physiological role. Adv Biochem Psychopharmacol 1969; 1:28-47.
12. Koella WP. Serotonin and sleep. Exp Med Surg 1969; 27:157-168.
13. Sirek A, Sirek OV. Serotonin: a review. Can Med Assoc J 1970; 102:846-849.
14. Bartlet AL, Gilbert FM. Estimation of urinary 5-hydroxytryptamine-O-glucuronide, a metabolite of endogenous 5-hydroxytryptamine in sheep. Br J Pharmacol 1971; 41:530-539.
15. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993; 262:578-580.
16. Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, et al. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet 1993; 52:1032-1039.
17. Pletscher A. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Br J Pharmacol Chemother 1968; 32:1-16.
18. Borcsiczky D, Szalay F, Tekes K, Tarcali J, Magyar K, de Chatel R. Platelet serotonin (5-HT) content is decreased in patients with alcoholic liver cirrhosis, but elevated in Gilbert's syndrome. J Hepatol 1996; 25:781-782.
19. Peters WH, te Morsche RH, Roelofs HM. Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome. J Hepatol 2003; 38:3-8.
20. Kohle C, Mohrle B, Munzel PA, Schwab M, Wernet D, Badary OA, et al. Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem Pharmacol 2003; 65:1521-1527.
21. Krishnaswamy S, Duan SX, Von Moltke LL, Greenblatt DJ, Court MH. Validation of serotonin (5-hydroxytryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6. Drug Metab Dispos 2003; 31:133-139.
22. Krishnaswamy S, Hao Q, Von Moltke LL, Greenblatt DJ, Court MH. Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6. Drug Metab Dispos 2004; 32:862-869.
23. Krishnaswamy S, Hao Q, Al-Rohaimi A, Hesse LM, von Moltke LL, Greenblatt DJ, Court MH. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S). J Pharmacol Exp Ther 2005; 313:1340-1346.